File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma

TitleWhole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
Authors
Lim, JQHuang, DTang, TTan, DLaurensia, YPeng, RJWong, EKYCheah, DMZChia, BKHIqbal, JGrigoropoulos, NFNairismägi, MLNg, CCYRajasegaran, VHong, HKim, SJCho, JTse, EMow, BCai, QCPoon, LMCai, QQTan, JChan, JYLim, JXGoh, YTPhipps, CRötzschke, OCheng, CLHa, JCHKhoo, LPLoh, YSMAu Yeung, RChan, TSYKwong, YLHwang, WKim, WSBei, JXLin, TOng, CKLim, ST
Issue Date2020
PublisherSpringer Nature [academic journals on nature.com]. The Journal's web site is located at http://www.nature.com/leu
Citation
Leukemia, 2020, v. 34, p. 3413-3419 How to Cite?
DOI: http://dx.doi.org/10.1038/s41375-020-1000-0
DescriptionHybrid open access
Persistent Identifierhttp://hdl.handle.net/10722/289374
ISSN
0887-6924
2021 Impact Factor: 12.883
2020 SCImago Journal Rankings: 4.539
PubMed Central ID
PMC7685978
ISI Accession Number ID
WOS:000555735700001

 

DC FieldValueLanguage
dc.contributor.authorLim, JQ-
dc.contributor.authorHuang, D-
dc.contributor.authorTang, T-
dc.contributor.authorTan, D-
dc.contributor.authorLaurensia, Y-
dc.contributor.authorPeng, RJ-
dc.contributor.authorWong, EKY-
dc.contributor.authorCheah, DMZ-
dc.contributor.authorChia, BKH-
dc.contributor.authorIqbal, J-
dc.contributor.authorGrigoropoulos, NF-
dc.contributor.authorNairismägi, ML-
dc.contributor.authorNg, CCY-
dc.contributor.authorRajasegaran, V-
dc.contributor.authorHong, H-
dc.contributor.authorKim, SJ-
dc.contributor.authorCho, J-
dc.contributor.authorTse, E-
dc.contributor.authorMow, B-
dc.contributor.authorCai, QC-
dc.contributor.authorPoon, LM-
dc.contributor.authorCai, QQ-
dc.contributor.authorTan, J-
dc.contributor.authorChan, JY-
dc.contributor.authorLim, JX-
dc.contributor.authorGoh, YT-
dc.contributor.authorPhipps, C-
dc.contributor.authorRötzschke, O-
dc.contributor.authorCheng, CL-
dc.contributor.authorHa, JCH-
dc.contributor.authorKhoo, LP-
dc.contributor.authorLoh, YSM-
dc.contributor.authorAu Yeung, R-
dc.contributor.authorChan, TSY-
dc.contributor.authorKwong, YL-
dc.contributor.authorHwang, W-
dc.contributor.authorKim, WS-
dc.contributor.authorBei, JX-
dc.contributor.authorLin, T-
dc.contributor.authorOng, CK-
dc.contributor.authorLim, ST-
dc.date.accessioned2020-10-22T08:11:44Z-
dc.date.available2020-10-22T08:11:44Z-
dc.date.issued2020-
dc.identifier.citationLeukemia, 2020, v. 34, p. 3413-3419-
dc.identifier.issn0887-6924-
dc.identifier.urihttp://hdl.handle.net/10722/289374-
dc.descriptionHybrid open access-
dc.languageeng-
dc.publisherSpringer Nature [academic journals on nature.com]. The Journal's web site is located at http://www.nature.com/leu-
dc.relation.ispartofLeukemia-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleWhole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma-
dc.typeArticle-
dc.identifier.emailTse, E: ewctse@hku.hk-
dc.identifier.emailAu Yeung, R: rex.auyeung@hku.hk-
dc.identifier.emailChan, TSY: drtchan@hku.hk-
dc.identifier.emailKwong, YL: ylkwong@hkucc.hku.hk-
dc.identifier.authorityTse, E=rp00471-
dc.identifier.authorityAu Yeung, R=rp01877-
dc.identifier.authorityKwong, YL=rp00358-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1038/s41375-020-1000-0-
dc.identifier.pmid32753688-
dc.identifier.pmcidPMC7685978-
dc.identifier.scopuseid_2-s2.0-85088976894-
dc.identifier.hkuros316401-
dc.identifier.volume34-
dc.identifier.spage3413-
dc.identifier.epage3419-
dc.identifier.isiWOS:000555735700001-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl0887-6924-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats